Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

Abstract Background Melanoma is an aggressive form of skin cancer, and patients with NRAS-mutant melanoma face limited treatment options due to the lack of direct NRAS inhibitors. This study explores the utilization of antisense oligonucleotides (ASOs) to directly target NRAS-mRNA for therapeutic ap...

Descripció completa

Dades bibliogràfiques

Autors principals:	Valentin Feichtenschlager, Yixuan James Zheng, Tiange Qu, Dasha Hohlova, Ciara Callanan, Linan Chen, Christopher Chen, Wilson Ho, Albert Lee, Yeonjoo Hwang, Arowyn Courtright, Thy Nguyen, Olivia Marsicovetere, Denise P. Muñoz, Klemens Rappersberger, Jean-Philippe Coppe, Susana Ortiz-Urda
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-06-01
Col·lecció:	Communications Medicine
Accés en línia:	https://doi.org/10.1038/s43856-025-00932-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!